Quintiles Information Library Custom Feed

Intarcia and Quintiles Finalize Innovative Alliance

Tue, 13 Dec 2011 07:43:17 -0400

December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

Quintiles Launches China CRO, Kun Tuo

Tue, 13 Dec 2011 07:01:52 -0400

December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

Strategic Alliances

Mon, 05 Dec 2011 15:24:16 -0400

Strategic alliances with specialized external partners allow companies to increase agility and the efficiency of processes, variablize resources and raise the number of promising drug candidates in their pipeline. Download the PDF

Understanding the Complexity of HTA Networks

Sun, 27 Nov 2011 15:07:38 -0400

As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. Download the PDF

Quintiles Acquires VCG & Associates and VCG Bio

Wed, 19 Oct 2011 08:30:00 -0400

October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

Partnering to Maximize Rewards in Pharmerging Markets

Thu, 15 Sep 2011 18:36:17 -0400

In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. Download the PDF

Quintiles, Kadrige Open E-Solutions Operation in the US

Tue, 02 Aug 2011 09:07:36 -0400

August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.

Podcast: Key FSP stakeholders - roles, relationships and impacts

Mon, 16 May 2011 11:27:27 -0400

Fred Cooley, Senior Director, Clinical Operations, North America Field Monitoring Group, describes key stakeholders in Functional Service Provider Relationships.

Podcast: The Benefits and Drawbacks of Functional Service Provider Arrangements (FSPs)

Mon, 16 May 2011 11:23:31 -0400

Ian Birks, Vice President, Integration, Resourcing, Metrics & Reporting, discusses the benefits and drawbacks of Functional Service Provider Arrangements (FSPs)

Quintiles and Population Genetics Technologies Partner

Mon, 16 May 2011 00:00:00 -0400

May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

Dr. Frank Massam

Fri, 13 May 2011 22:01:05 -0400

Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

Quintiles Named a Preferred Provider to Global Health Product Development Partnership Consortium

Fri, 25 Mar 2011 07:18:56 -0400

March 25, 2011 – Quintiles has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).

Quintiles Supports Samsung's Entry into BioPharma Market through Joint Venture

Mon, 28 Feb 2011 00:00:00 -0400

February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.

H1N1 - Proactive Engagement

Tue, 01 Feb 2011 14:06:59 -0400

Despite short timelines and government requirements, an H1N1 vaccine study finished in time for the influenza season. Download the PDF

Promoting Prevention

Tue, 01 Feb 2011 13:37:46 -0400

How do you recruit for an influenza vaccine trial off-season? Quintiles tapped our Partner Sites and completed enrollment in just four days. Download the PDF

The New Health Alliance

Mon, 10 Jan 2011 12:00:00 -0400

Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders. Download the PDF

Flexible Capacity

Wed, 24 Nov 2010 11:25:36 -0400

Working with an ally who could deliver process efficiencies and cost-savings on a global scale, this company was able to expand its global portfolio. Download the PDF

Employing Confidence

Mon, 11 Oct 2010 13:46:16 -0400

A top-10 pharmaceutical company turned to Quintiles to quickly integrate and deploy a large-scale sales force expansion in anticipation of multiple new product launches.

QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL

Wed, 06 Oct 2010 12:00:00 -0400

October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.

QUINTILES, HKPI, RAMCO ANNOUNCE JOINT VENTURE IN EGYPT

Wed, 29 Sep 2010 08:58:07 -0400

September 29, 2010 - Quintiles, Health Kare Pharma International (HKPI), and Ramco Import and Export today announced the formation of a joint venture to provide commercialization services in Egypt.

Scaling Up for Safety: How to Gain Efficiencies without Sacrificing Quality

Thu, 16 Sep 2010 16:30:24 -0400

Read how Quintiles set-up a complete pharmacovigilance operation in a developing region in only six months for a leading pharma company. Download the PDF

Global Data Solutions

Wed, 15 Sep 2010 11:18:01 -0400

Quintiles leveraged its unmatched experience and regional presence to open a free-standing, closed source data management center of excellence. Download the PDF

Re-energizing a Brand

Wed, 01 Sep 2010 14:06:53 -0400

Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size. Download the PDF

PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

Tue, 31 Aug 2010 09:00:00 -0400

August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

QUINTILES ANNOUNCES NEW EUROPEAN HEADQUARTERS

Thu, 29 Jul 2010 13:46:48 -0400

July 29, 2010 - Quintiles, announced that it is re-locating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading overlooking the M4 motorway.

Capital - sharing risks, expanding opportunities

Wed, 14 Jul 2010 13:56:56 -0400

This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards. Download the PDF

Doctors and Sales Reps

Wed, 07 Jul 2010 09:57:45 -0400

Pharmaceutical companies are faced with a difficult question, should they invest in an inhouse sales force to market their product or does it make sense

Outsourcing Exceeds Expectations

Wed, 30 Jun 2010 12:58:51 -0400

In Quintiles, Lilly found an ally with a kindred commitment to a best-in-class culture, plus a readiness to innovate in a challenging market. Download the PDF

Syndicated Solutions

Wed, 30 Jun 2010 12:03:23 -0400

Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk. Download the PDF

Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment

Wed, 30 Jun 2010 12:00:00 -0400

Targeting Oncology

Wed, 02 Jun 2010 15:36:02 -0400

Learn more about Quintiles leadership in oncology product development and commercialization. Download the PDF

Eric Siemers, MD

Thu, 20 May 2010 09:25:02 -0400

Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

Rigorous Planning

Sun, 09 May 2010 22:35:13 -0400

A large pharma company needed to establish a pilot screening program with 50 participating practices, identify 4,500 people at risk and perform 2,500 bone densitometries in just nine months. Download the PDF

Global Flexibility

Sun, 09 May 2010 22:27:31 -0400

PharmaMar needed to mobilize an effective sales force covering a market that spanned several countries and 20 official languages. With Quintiles, on-time recruitment against aggressive timelines made it possible to top sales goals in the first year. Download the PDF

Blockbuster Co-Promotion

Sun, 09 May 2010 22:20:30 -0400

A pharma company targeted seven countries for quickly promoting its new compound. In just four months, Quintiles recruited, trained and implemented highly effective field sales teams in all seven new countries. Download the PDF

Agile Outsourcing

Sun, 09 May 2010 22:10:54 -0400

Read how Quintiles established a pan-European infrastructure, recruited senior management and was achieving KPIs across 12 countries in just eight months. Download the PDF

Bridging Cultures

Sun, 09 May 2010 21:48:09 -0400

Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. Download the PDF

Focused Co-Promotion

Sun, 09 May 2010 21:39:20 -0400

Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth. Download the PDF

Collaborative Promotion

Sun, 09 May 2010 21:21:40 -0400

Learn what happened when Quintiles was chosen to fulfill and manage a syndicated project working closely with a woundcare company's sales team. Download the PDF

Emerging Biopharma Service Fact Sheet

Tue, 04 May 2010 00:25:54 -0400

Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies. Download the PDF

The Power of Consolidation: How to Gain Efficiencies without Sacrificing Quality

Wed, 31 Mar 2010 12:00:00 -0400

Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management. Download the PDF

Mapping the Future in Oncology Drug Development

Mon, 29 Mar 2010 12:21:45 -0400

A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. Download the PDF

PharmAsia News Article Reprint

Mon, 01 Mar 2010 09:21:33 -0400

Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News. Download the PDF

QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA

Tue, 16 Feb 2010 09:43:33 -0400

February 16, 2010 - Quintiles announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.

QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE

Thu, 28 Jan 2010 10:32:01 -0400

January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.

Managing Alliances with the Balanced Scorecard

Mon, 11 Jan 2010 06:00:00 -0400

“Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies. Download the PDF

Managing Alliances with the Balanced Scorecard

Mon, 11 Jan 2010 06:00:00 -0400

Robert S. Kaplan, Baker Foundation Professor at Harvard Business School, explains why corporate alliances often fail, and how Solvay Pharmaceuticals and Quintiles achieved success through

Managing Alliances with the Balanced Scorecard

Mon, 11 Jan 2010 06:00:00 -0400

One particularly well done aspect of the Solvay-Quintiles alliance was its use of multiple committees and teams to keep the alliance on track and deliver

QUINTILES’ SUCCESS IN MANAGING STRATEGIC ALLIANCES PROFILED IN HARVARD BUSINESS REVIEW

Mon, 11 Jan 2010 06:00:00 -0400

January 11, 2010 - “Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies.

QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD

Mon, 14 Dec 2009 12:02:36 -0400

December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.

Hepatitis B Vaccine-Successful Study Strategy in Asia

Mon, 09 Nov 2009 16:48:01 -0400

Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. Download the PDF

QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

Fri, 06 Nov 2009 10:47:04 -0400

November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

Coordinating Safety Across Functions and Phases

Tue, 03 Nov 2009 17:43:07 -0400

Facing significant challenges with clinical and post-marketing safety, a customer needed an ally who could provide a full range of safety and risk management solutions. Download the PDF

QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH

Mon, 26 Oct 2009 11:53:57 -0400

October 26, 2009 - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London sign collaborative agreement with Quintiles.

Enabling Transformation

Wed, 30 Sep 2009 13:22:07 -0400

Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. Download the PDF

QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT

Fri, 25 Sep 2009 09:54:10 -0400

September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®.

QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS

Thu, 24 Sep 2009 11:39:33 -0400

September 24, 2009 - Quintiles Transnational Corp. announced the opening of an expanded regional facility near Edinburgh, Scotland; space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management.

QUINTILES ANNOUNCES CLINICAL RESEARCH PARNERSHIP WITH THE UNIVERSITY OF PRETORIA

Thu, 10 Sep 2009 13:54:23 -0400

September 10, 2009 – Quintiles Prime Site Program expands into South Africa to accelerate clinical development.

Sales force project scorecard

Fri, 14 Aug 2009 13:27:09 -0400

This chart is typical of a project involving many markets, enabling project performance oversight from the multi-country project level down to a single KPI. Download the PDF

Project Performance – KPIs

Fri, 14 Aug 2009 13:24:16 -0400

This is yet another way of looking at sales performance, this time by monitoring performance against the full basket of KPIs at a project level. Download the PDF

Innovex Coversation: Coaching Support

Fri, 14 Aug 2009 12:07:10 -0400

Innovex uses their worldwide online coaching tool, Innovex Innsight, to support first line managers and reps in their coaching process. Download the PDF

Should Venture Firms Bundle Their Biotech Portfolios?

Mon, 29 Jun 2009 10:18:43 -0400

Ron Wooten, president of the investment and business-development unit of Quintiles, a contract-research organization, thinks so.

Poised for success

Tue, 16 Jun 2009 17:56:39 -0400

Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility Download the PDF

QUINTILES WINS PFIZER DEVELOPMENT OPERATIONS STRATEGIC SUPPLIER EXCELLENCE AWARD

Wed, 10 Jun 2009 13:47:36 -0400

JUNE 10, 2009 – Quintiles announces that its Data Management division has received the 2008 Pfizer Development Operations’ Strategic Supplier Excellence Award.

Anatomy of a Managed Partnership

Tue, 26 May 2009 20:55:45 -0400

Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs. Download the PDF

Making the Most of a Smart Move

Thu, 26 Mar 2009 15:04:23 -0400

In late 2007, Scotland-based ProStrakan Group plc seemed to have everything going for it: four new European product introductions planned for an 18-month period and near-term product launches with an aggregate peak sales potential of $400 to $500 million, both backed by a 340-person pan-European salesforce. Download the PDF

Grabbing a Leadership Position

Thu, 26 Mar 2009 14:59:19 -0400

Astellas-Quintiles Alliance Establishes Market Leadership Platform for Vesicare Download the PDF

Adrian McKemey, Ph.D.

Wed, 25 Mar 2009 13:52:40 -0400

Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.

Gain Capital & Retain Value

Tue, 24 Mar 2009 13:30:18 -0400

Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product. Download the PDF

Matching Risks with Rewards

Tue, 24 Mar 2009 13:08:43 -0400

A global pharmaceutical company had a new formulation of a core strategic asset half way through its pivotal Phase III studies, but another major product launch at the company was generating such significant expenses that it was squeezing the budget for this and other development programs. Download the PDF

Jumpstarting a Phase III Candidate

Tue, 24 Mar 2009 12:54:16 -0400

A global pharmaceutical company had a promising new formulation of a marketed product in early Phase III trials, but R&D budget pressures were likely to result in delays getting the product to market. Download the PDF

Joining Forces

Thu, 19 Mar 2009 11:53:21 -0400

Global partnership enable big pharma to streamline drug development and refocus their efforts on core competencies. Download the PDF